Mitchell Sinkler & Starr’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.44M Buy
21,432
+139
+0.7% +$32.4K 2.27% 10
2026
Q1
$5.2M Sell
21,293
-354
-2% -$82.5K 2.4% 9
2025
Q4
$4.48M Sell
21,647
-219
-1% -$43.3K 2.02% 9
2025
Q3
$4.05M Sell
21,866
-140
-0.6% -$24K 1.82% 9
2025
Q2
$3.36M Sell
22,006
-42,813
-66% -$6.58M 1.61% 15
2025
Q1
$10.7M Sell
64,819
-3,821
-6% -$598K 3.01% 5
2024
Q4
$9.93M Sell
68,640
-16,731
-20% -$2.59M 2.65% 8
2024
Q3
$12.5M Buy
85,371
+7,588
+10% +$1.21M 3.13% 4
2024
Q2
$12M Sell
77,783
-1,103
-1% -$164K 3.08% 6
2024
Q1
$12.5M Sell
78,886
-55,101
-41% -$8.77M 3.12% 6
2023
Q4
$21M Buy
133,987
+34,888
+35% +$5.35M 3.82% 4
2023
Q3
$15.4M Buy
99,099
+17,642
+22% +$2.91M 4.75% 3
2023
Q2
$13.5M Sell
81,457
-20
-0% -$3.23K 3.83% 3
2023
Q1
$12.6M Buy
81,477
+9,449
+13% +$1.53M 3.73% 4
2022
Q4
$12.7M Buy
72,028
+2,597
+4% +$448K 4.1% 4
2022
Q3
$11.3M Buy
69,431
+2,180
+3% +$369K 4.4% 5
2022
Q2
$11.9M Buy
67,251
+672
+1% +$120K 4.38% 6
2022
Q1
$11.8M Buy
66,579
+348
+0.5% +$59.2K 3.69% 7
2021
Q4
$11.3M Buy
66,231
+51,030
+336% +$8.35M 3.36% 9
2021
Q3
$2.46M Sell
15,201
-180
-1% -$30.7K 2.22% 5
2021
Q2
$2.53M Sell
15,381
-190
-1% -$31.5K 2.3% 5
2021
Q1
$2.56M Sell
15,571
-2,321
-13% -$376K 2.48% 5
2020
Q4
$2.82M Sell
17,892
-1,252
-7% -$185K 2.69% 6
2020
Q3
$2.85M Buy
19,144
+935
+5% +$138K 2.9% 5
2020
Q2
$2.56M Buy
18,209
+10
+0.1% +$1.46K 2.91% 5
2020
Q1
$2.39M Sell
18,199
-520
-3% -$73.8K 3.12% 4
2019
Q4
$2.73M Buy
18,719
+2,725
+17% +$370K 2.9% 3
2019
Q3
$2.07M Sell
15,994
-299
-2% -$39.4K 2.65% 6
2019
Q2
$2.27M Sell
16,293
-25
-0.2% -$3.46K 2.59% 7
2019
Q1
$2.28M Sell
16,318
-879
-5% -$118K 2.63% 7
2018
Q4
$2.22M Sell
17,197
-205
-1% -$28.6K 2.74% 7
2018
Q3
$2.4M Sell
17,402
-600
-3% -$79.7K 2.51% 6
2018
Q2
$2.18M Sell
18,002
-308
-2% -$38.4K 2.41% 8
2018
Q1
$2.35M Sell
18,310
-425
-2% -$57.4K 2.68% 5
2017
Q4
$2.62M Sell
18,735
-70
-0.4% -$9.75K 3.88% 1
2017
Q3
$2.44M Buy
18,805
+266
+1% +$35.3K 3.83% 2
2017
Q2
$2.45M Buy
18,539
+775
+4% +$98.9K 4.02% 2
2017
Q1
$2.21M Sell
17,764
-8,713
-33% -$1.04M 3.59% 2
2016
Q4
$3.05M Sell
26,477
-1,115
-4% -$129K 4.28% 2
2016
Q3
$3.26M Sell
27,592
-800
-3% -$97.1K 5.11% 1
2016
Q2
$3.44M Sell
28,392
-555
-2% -$63.1K 4.7% 1
2016
Q1
$3.13M Sell
28,947
-1,555
-5% -$161K 4.32% 1
2015
Q4
$3.13M Sell
30,502
-2,857
-9% -$287K 4.28% 1
2015
Q3
$3.11M Hold
33,359
4.01% 2
2015
Q2
$3.25M Sell
33,359
-68
-0.2% -$6.81K 3.84% 2
2015
Q1
$3.36M Sell
33,427
-1,165
-3% -$118K 3.78% 2
2014
Q4
$3.62M Hold
34,592
4.04% 2
2014
Q3
$3.69M Sell
34,592
-1,276
-4% -$132K 4.12% 2
2014
Q2
$3.75M Sell
35,868
-310
-0.9% -$31.3K 4.03% 2
2014
Q1
$3.55M Sell
36,178
-280
-0.8% -$26K 3.98% 2
2013
Q4
$3.34M Sell
36,458
-3,960
-10% -$365K 3.75% 2
2013
Q3
$3.5M Sell
40,418
-274,622
-87% -$24.6M 4.01% 2
2013
Q2
$27M Buy
+315,040
New +$26.7M 5.93% 1

Other funds holding JNJ

Mitchell Sinkler & Starr's JNJ Position: Q2 2026 in Review

Mitchell Sinkler & Starr increased its Johnson & Johnson (JNJ) stake by 0.65% in Q2 2026, buying an estimated $32.4K and bringing the position to 21,432 shares worth $5.44M. The position accounts for 2.27% of the portfolio, ranked #10.

Mitchell Sinkler & Starr first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $27M in Q2 2013. 1,584 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Mitchell Sinkler & Starr held 21,432 shares of Johnson & Johnson worth $5.44M as of Q2 2026.
  • Mitchell Sinkler & Starr bought 139 Johnson & Johnson shares in Q2 2026, an estimated $32.4K.
  • Johnson & Johnson made up 2.27% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #10 holding.
  • Mitchell Sinkler & Starr first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Mitchell Sinkler & Starr's Johnson & Johnson position peaked at $27M in Q2 2013.
  • 1,584 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.